Clinical Trial

Reduce Inefficiencies in Management of Spasticity

Study acronym: ReIMage
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the effectiveness of a spasticity screener and to determine if the spasticity screener results are useful to healthcare providers and impact clinical decision making
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-04.
Trial Details
NCT Number NCT07639632
Lead Sponsor The University of Texas Health Science Center, Houston
Collaborators: AbbVie
Conditions Stroke
Enrollment 80 participants
Start Date 2026-06-15
Primary Completion 2029-08-01 (estimated)
Study Completion 2029-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-12